(NASDAQ: ASPI) Asp Isotopes's forecast annual revenue growth rate of 239.07% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 2.72%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.84%.
Asp Isotopes's revenue in 2026 is $8,383,354.On average, 5 Wall Street analysts forecast ASPI's revenue for 2026 to be $4,817,000,862, with the lowest ASPI revenue forecast at $3,886,830,558, and the highest ASPI revenue forecast at $5,823,429,170. On average, 5 Wall Street analysts forecast ASPI's revenue for 2027 to be $10,909,882,368, with the lowest ASPI revenue forecast at $9,697,513,114, and the highest ASPI revenue forecast at $12,821,985,313.
In 2028, ASPI is forecast to generate $42,631,327,724 in revenue, with the lowest revenue forecast at $40,959,858,684 and the highest revenue forecast at $43,886,037,905.